RM Global Raises Additional $34 Million for Israel-Based Biopharma Investment Fund
New York-headquartered investment banking firm RM Global Partners LLC announced it raised an additional $34 million in funding for its Israel-based RMGP Biopharma Investment Fund Monday. The fund has raised a total of $64 million in aggregate fund commitments to date. The fund's portfolio is made up of 11 startups…
Continue Reading
Subscribe to unlock the full article and access premium financial content.
Click here to read the full story: CTech